Nexstim Oyj
Explore this company’s associated devices, FDA decisions and regulatory history.

Nexstim Oyj
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Nexstim Oyj. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 20, 2026 to Mar 20, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code OBP appears in 2 of the 2 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Elimäenkatu 9b, Helsinki, 00510, FI. Recorded on K253098, decision dated Mar 20, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)
K253098 · 510(k) clearanceNexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)
K252358 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.